DEC 18, 2020 6:51 AM PST

Not Just THC and CBD: Study Investigates Potential of Minor Cannabinoids

WRITTEN BY: Angela Dowden

Cannabinoids are the natural compounds in the cannabis plant that interact with the body's endocannabinoid system. Despite largely hearing about CBD (cannabidiol) and THC (tetrahydrocannabinol) there are actually many more minor cannabinoids in the plant, but their impact on health has largely been undiscovered.

Now a new Canadian study from the Pharmacy and Nutrition unit at the University of Saskatchewan, Saskatoon has attempted to categorise and assign activities to some of these cannabinoids both in vitro and in vivo. For the in vitro part of the study the cannabinoids were tested at the CB1 and CB2 cannabinoid receptor sites of Chinese hamster ovary cells and for the in vivo part cannabinoids were administered to mice

The teams assessed the activity of 8 cannabinoids: these were THC and CBD as well as six minor cannabinoids, namely tetrahydrocannabinolic acid (THCA), tetrahydrocannabivarin (THCV), cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabigerol (CBG), and cannabichromene (CBC).

The results showed differential binding to CH1 and C2 along lines already reported:  all eight cannabinoids tested had some level of binding to CB1 but, other than for THC, this binding was weak. Most of the cannabinoids also bound to CB2, including THC, but  CBD bound poorly to this receptor.

In the mice, they found that THC, THCA, and THCV—but not CBD—reduced pain, while THC, CBD, THCA, THCV, and CBG all had a positive impact on anxiety.

The authors concluded THCA and THCV, which bound both CB1 and CB2, may be able to reduce pain, inflammation, and anxiety when either is used in the absence of other cannabinoids. This finding is significant since there is a growing interest in the clinical applications of single-cannabinoid preparations.

However the authors say that further study is warranted to see what other receptors other than just CB1 and CB2 might be important. They also commented that cannabis is a special case compared with most pharmaceuticals that have single active ingredients.

“Cannabis products contain many phytomolecules that are co-administered when Cannabis is consumed. This study represents an initial foray into potential between- and among-biomolecule interactions that can be built upon gradually. Pharmacology is a reductionist approach to biochemical interactions that cannot always model the complex interactions occurring in nature”. 

The National Institute for Health is already investigating various minor cannabinoids and terpenes in cannabis for their pain-relieving benefits; it was announced in September 2019.

 

Sources: Nature, Marijuana Business Daily

 

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
MAR 21, 2021
Microbiology
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
MAR 21, 2021
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
A mouse model has shown that it's possible to clear a multi-drug resistant gonorrhea with only one dose of antibioti ...
APR 02, 2021
Genetics & Genomics
A New Neurodevelopmental Disorder is ID'ed
APR 02, 2021
A New Neurodevelopmental Disorder is ID'ed
Researchers have identified a genetic disease that causes neurodevelopmental disorders in some affected kids. The diseas ...
APR 05, 2021
Neuroscience
Could a Keto Diet Treat Alzheimer's Disease?
APR 05, 2021
Could a Keto Diet Treat Alzheimer's Disease?
  Researchers from Brigham Young University have found evidence that eating a ketogenic diet- which is a diet that ...
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
APR 15, 2021
Technology
New Technique for Creating Nanofibers Could Help Produce Affordable, Effective Mask Filters to Combat COVID-19
APR 15, 2021
New Technique for Creating Nanofibers Could Help Produce Affordable, Effective Mask Filters to Combat COVID-19
Recently, nanofibers have been used to improve the filtration quality of protective face masks and help them filter airb ...
APR 19, 2021
Genetics & Genomics
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
APR 19, 2021
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
Researchers have suggested that it's time for medicine to move away from demographic labels that are too narrow to captu ...
Loading Comments...